Shanghai Pharmaceuticals (HK) Investment Ltd 3
3 · Oncternal Therapeutics, Inc. · Filed Jul 23, 2020
Insider Transaction Report
Form 3
Holdings
- 1,049,317
Common Stock
Warrants
[F1]Exercise: $2.32Exp: 2026-01-21→ Common Stock (524,658 underlying)
Footnotes (1)
- [F1]The warrants are currently exercisable into shares of the Issuer's Common Stock except to the extent that the exercise would result in the beneficial ownership of more than 19.99% of the Issuer's outstanding Common Stock.
Signature
SHANGHAI PHARMACEUTICALS (HK) INVESTMENT LIMITED, By: Shanghai Pharmaceuticals Holding Co., Ltd., its sole member, By: /s/ Shen Bo, Name: Shen Bo, Title: Authorized Signatory|2020-07-23